A Flood of IPO Shares is Coming
India's stock market faces a major test as a packed schedule of IPO lock-up expiries begins April 1, releasing about $68 billion in shares from 95 companies by July 31. This concentrated supply, often involving large stakes in companies, enters a market marked by investor caution and negative sentiment. By late March 2026, major indices like the Sensex and Nifty had fallen significantly in the first quarter. They were pressured by geopolitical tensions, rising oil prices, a weaker rupee, and consistent selling by foreign investors. This environment makes the market highly vulnerable to the upcoming release of shares.
Key IPOs Face Major Share Unlocks
From April to July 2026, a tight sequence of share unlocks is planned. April 13 alone sees Tata Capital release 67% of its equity. May brings large unlocks from Lenskart Solutions (60%) and Pine Labs (80%). In June, Meesho is set to offer 68% of its shares. This surge of stock ready for trading will directly test investor interest, especially considering how recent IPOs have performed. During fiscal year 2026, about two out of every three IPOs have traded below their initial price. The average gain on listing has shrunk to 8%, and the overall average IPO return turned negative at -7% by March 27, 2026. This shows a significant drop in investor excitement and new expectations for new listings.
High Valuations Face Reality Check
The sheer volume and concentration of these lock-up expiries will test the valuations of many recently listed companies. Lenskart Solutions, for example, trades at a Price-to-Earnings (P/E) ratio of about 260-294x. Pine Labs has P/E multiples ranging from 148x to over 677x. These valuations seem out of step with current market conditions, where investor sentiment is cautious and many companies are seeing price drops. For comparison, the Nifty Financial Services index trades at a P/E of 21.69, just above its 7-year median. The Consumer Durables sector trades at a P/E of 57.62, below its 7-year median of 68.66. Coal India offers a more modest valuation at a P/E around 9.59x, well below its industry average. Meesho, which is not profitable, already trades with a negative P/E. The flood of shares could force a reassessment of these high multiples, potentially leading to significant price drops for companies that cannot justify their current valuations based on performance.
Demand Weakness and Fundamental Risks
The main risk comes from a mismatch between share supply and investor demand. With foreign institutional investors (FIIs) continuing to sell and domestic retail investor interest softening, it's uncertain if the market can absorb such a large volume of new shares without significant price drops. Many companies facing these unlocks operate in sectors that raised a lot of money through IPOs but haven't shown matching earnings growth. Some analysts see the current IPO market weakness as a normal cyclical correction after a period of high liquidity and inflated valuations. The sustained weak market performance in FY26, with the Sensex and Nifty ending the year down, further reduces the chances of smooth absorption. Companies with weaker finances, high debt, or unproven business models will be most vulnerable to selling pressure from the increased supply. This could lead not just to a temporary dip, but to sustained underperformance as early investors sell and new supply pushes stock prices down, especially for companies whose valuations were based more on excitement than on stable profits.
Navigating the Market Ahead
Although the market faces considerable pressure from the lock-up expiries, some analysts believe the broader market correction might already be factored in. They see potential for recovery once macroeconomic conditions improve. However, the immediate outlook is cautious. The large volume of shares entering the market over the next four months will remain a key factor in price setting. Investors will need to differentiate between companies with strong fundamentals and growth potential, which may eventually overcome the oversupply, and those whose valuations rely on ongoing market excitement, which face a higher risk of significant price drops. The next few months will act as a crucial test for the health and demand for India's recently listed companies.